Marilyn Dixon Hill v. HHS - Influenza, Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (2023)

Marilyn Dixon Hill filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuritis (CIDP) as a result of her November 10, 2010, influenza vaccination. The respondent initially recommended against compensation but later filed an amended report conceding that Ms.

Hill was entitled to compensation. The respondent agreed that her condition met the criteria set forth in the Vaccine Injury Table and the Qualifications and Aids to Interpretation for GBS.

The respondent also confirmed that she received the vaccine in the United States, satisfied the severity requirement of suffering residual effects for more than six months, and filed her petition timely. Based on the respondent's concession and the evidence of record, the Special Master found Ms.

Hill entitled to compensation. Subsequently, a decision awarding damages was issued.

The respondent proffered an award of $637,213.42, which included $196,500.00 for pain and suffering, $434,357.06 for lost wages, and $6,356.36 for past unreimbursable medical expenses. Ms.

Hill agreed with this proffered award. The Special Master awarded Ms.

Hill the lump sum of $637,213.42.